CAS 131086-18-5

Fórmula: C31H38BrNO11

InChI: InChI=1S/C31H38BrNO11/c1-5-41-31(13-32,42-6-2)30(39)11-16-22(19(12-30)44-20-10-17(33)25(34)14(3)43-20)29(38)24-23(27(16)36)26(35)15-8-7-9-18(40-4)21(15)28(24)37/h7-9,14,17,19-20,25,34,36,38-39H,5-6,10-13,33H2,1-4H3/t14-,17-,19-,20-,25+,30-/m0/s1

Chave InChI: BDBRNKHVDGFCDV-AXMMXYKRSA-N

SMILES: CCOC(CBr)([C@]1(C[C@@H](C2=C(C1)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4OC)O)O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O)N)O)OCC

Doxorubicin Impurity 15 HBr

CAS: 131086-18-5

Fórmula: C₃₁H₃₈BrNO₁₁·HBr

Cor e Forma: Dark Red Solid

Peso molecular: 680.55 80.91

Ref: 4Z-D-3431

Doxorubicin Impurity 15

CAS: 131086-18-5

Doxorubicin impurity 15 is a natural product that is used as an analytical reference standard in pharmacopoeia. It has been synthesized for use in drug development and research and development, and is available as a high-purity HPLC standard. Doxorubicin impurity 15 has a CAS number of 131086-18-5.

Fórmula: C₃₁H₃₈BrNO₁₁

Pureza: Min. 95%

Peso molecular: 680.54 g/mol

Ref: 3D-ID163220

(8S-cis)-10-[(3-Amino-2,3,6-trideoxy-Alpha-L-lyxo-hexopyranosyl)oxy]-8-(2-bromo-1,1-diethoxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione Hydrobromide (Technichal Grade)

Produto Controlado

CAS: 131086-18-5

Applications (8S-cis)-10-[(3-Amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-8-(2-bromo-1,1-diethoxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione hydrobromide is an impurity of Doxorubicin (D558000), an antineoplastic agent.
References Di Marco, A., et al.: Cancer Chemother. Rep., (part 1), 53, 33 (1969); Mihich, E. and Ehrke, M.J.: Transplant. Proc., 16, 499 (1984);

Fórmula: C₃₁H₃₈BrNO₁₁·HBr

Cor e Forma: Neat

Peso molecular: 761.45

Ref: TR-A630655

Doxorubicin Impurity 17

CAS: 131086-18-5

Fórmula: C₃₁H₃₈BrNO₁₁

Peso molecular: 680.5

Ref: ST-EA-CP-D102011